MA46503A1 - New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers - Google Patents
New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancersInfo
- Publication number
- MA46503A1 MA46503A1 MA46503A MA46503A MA46503A1 MA 46503 A1 MA46503 A1 MA 46503A1 MA 46503 A MA46503 A MA 46503A MA 46503 A MA46503 A MA 46503A MA 46503 A1 MA46503 A1 MA 46503A1
- Authority
- MA
- Morocco
- Prior art keywords
- cell epitopes
- peptides
- immunotherapy
- myeloma
- cells
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 206010035226 Plasma cell myeloma Diseases 0.000 title abstract 2
- 238000009169 immunotherapy Methods 0.000 title abstract 2
- 201000000050 myeloid neoplasm Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 1
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000005975 antitumor immune response Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne des peptides, des protéines, des acides nucléiques et des cellules destinés à être utilisés dans des procédés immunothérapeutiques. L'invention concerne en particulier l'immunothérapie du cancer, en particulier du myélome. L'invention porte en outre sur des épitopes peptidiques de cellules t associés à des tumeurs, seuls ou combinés à d'autres peptides tumoraux, qui peuvent par exemple servir en tant que principes actifs pharmaceutiques de compositions vaccinales qui stimulent des réponses immunitaires antitumorales, ou qui stimulent des cellules t ex vivo ensuite transférées à un patient. Des peptides liés aux molécules du complexe majeur d'histocompatibilité (cmh), ou des peptides en tant que tels, peuvent également être des cibles d'anticorps, de récepteurs de cellules t solubles et d'autres molécules de liaison.The present invention relates to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. The invention relates in particular to the immunotherapy of cancer, in particular of myeloma. The invention further relates to tumor-associated peptide epitopes of t cells, alone or in combination with other tumor peptides, which can, for example, serve as pharmaceutical active ingredients in vaccine compositions which stimulate anti-tumor immune responses, or which stimulate ex vivo t cells then transferred to a patient. Peptides bound to major histocompatibility complex (cmh) molecules, or peptides as such, can also be targets of antibodies, soluble t cell receptors and other binding molecules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MA46503A MA46503A1 (en) | 2019-07-31 | 2019-07-31 | New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MA46503A MA46503A1 (en) | 2019-07-31 | 2019-07-31 | New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46503A1 true MA46503A1 (en) | 2021-04-30 |
Family
ID=75687912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA46503A MA46503A1 (en) | 2019-07-31 | 2019-07-31 | New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA46503A1 (en) |
-
2019
- 2019-07-31 MA MA46503A patent/MA46503A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46504A1 (en) | New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers | |
| MA42381A (en) | NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF ESOPHAGIC CANCER AND OTHER CANCERS | |
| MA46647A1 (en) | New peptides and combination of peptides for use in immunotherapy of pancreatic cancer and other cancers | |
| MA43490A1 (en) | New peptides and combination of peptides for use in immunotherapy against various cancers | |
| MA43435B1 (en) | NEW PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (SEQ ID 25 - MRAX5-003) | |
| MA43328A1 (en) | Transfected t-cells and t-cell receptors for use in immunotherapy against cancers | |
| MA41520B2 (en) | New peptides and peptide combination for use in immunotherapy against ovarian cancer and other cancers | |
| MA43330B1 (en) | Transfected T cells and T cell receptors for use in immunotherapy against cancers | |
| MA42294B1 (en) | New peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| MA46022A (en) | NEW PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | |
| MA43460A1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA43090A1 (en) | Peptides, peptide combinations and cell-based drugs for immunotherapy against urinary bladder cancer and other cancers | |
| MA44551A1 (en) | Novel peptides and novel combination of peptides for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers | |
| MA43719B1 (en) | PEPTIDE FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND SMALL CELL LUNG CANCER | |
| MA44101A (en) | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS | |
| MA41393B2 (en) | Novel peptides and combinations of peptides and scaffolds formed thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers | |
| MA41237B1 (en) | New peptides and peptide combinations for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers | |
| MA47367B1 (en) | NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | |
| MA46503A1 (en) | New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers | |
| MA46913B1 (en) | New peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| MA43596A1 (en) | New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers | |
| MA41664A1 (en) | Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers |